Navigation Links
PTS, Inc. Announces Two New Patents
Date:7/10/2013

INDIANAPOLIS, July 10, 2013 /PRNewswire/ -- Polymer Technology Systems, Inc. (PTS, Inc.), the U.S.-based manufacturer of the CardioChek® family of point-of-care diagnostic products, has announced the issuance of two new U.S. patents.  U.S. Patent No. 8,257,654 relates to the management of health data collected by point-of-care testing devices using a health report server.  U.S. Patent No. 8,307,531 covers a method and apparatus for manufacturing disposable dry test strips. 

"Our products are built upon a number of proprietary technologies and processes," says Robert Huffstodt, President and CEO of PTS, Inc.  "These patents, along with the other patents we hold, help PTS, Inc. maintain technological leadership for our customers."

U.S. Patent No. 8,257,654 is for a health report server that may receive medical data from a diverse set of point-of-care testing systems deployed in a hospital or other medical facility.  By utilizing a network-based system, medical data can be collected concerning patients and then securely and conveniently stored.  The system allows for medical data to then be distributed to those medical personnel who need it, such as doctors.  The system provides for simple menu-driven access to the stored medical information. 

PTS, Inc. has led the way in providing innovative connectivity solutions.  For example, the CardioChek HRA software captures biometric data and receives test results directly from a CardioChek PA analyzer to calculate a cardiac age based on an individual's risk factors using the Framingham Heart Study criteria.  And, CardioChek Link® data transfer software and cable provides for the output of test results from the CardioChek PA device into a computer spreadsheet file.

The intellectual property covered under U.S. Patent No. 8,307,531 not only provides for a m
'/>"/>

SOURCE Polymer Technology Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Neurotechnology Announces MegaMatcher Accelerator 6.0 High-speed, High-volume Multibiometric Identification Solution and Updates to Entire Biometric Product Line
2. Xyngular Announces the Launch of its New Xyng Enhanced Formula
3. Wiley announces increase in Impact Factors
4. PatientStream announces the industrys first Multilingual family waiting room board
5. DigitalPersona Announces U.are.U Software Development Kit (SDK) for Android Applications
6. Chiltern Announces The Promotion Of Alecia Barbee To VP, Global Biometrics
7. Scripps Research announces research & license agreement with Janssen Pharmaceuticals
8. Missouri Botanical Garden program announces collaboration with LHerboretum
9. DFG announces recipients of 2013 Heinz Maier-Leibnitz Prize
10. PLOS announces Accelerating Science Award Program
11. AAPS announces 2013 National Biotechnology Conference award winners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2014)... at the right time might actually help boost a ... help in understanding animal populations, pest control and managing ... the journal Trends in Ecology and Evolution , ... the kind of positive population effect an overall species ... on the size and developmental stage of the creatures ...
(Date:11/4/2014)... about the way our bodies are assembled during early ... they are supposed to become a nerve or a ... correct place and alignment? Researchers at the University of ... a new study, UM researchers describe the signaling systems ... at the head-trunk region. Their discovery may have important ...
(Date:11/4/2014)...   3D scanner ... Fuel3D , a developer of 3D scanning solutions, ... $6.4 million (£4 million). This funding builds on the company,s ... and paves the way for the commercial launch of the ... round was led by Chimera Partners and will be used ...
Breaking Biology News(10 mins):When less is more: Death in moderation boosts population density in nature 2The inside story: How the brain and skull stay together 2Fuel3D Secures $6.4 Million in Expansion Funding 2Fuel3D Secures $6.4 Million in Expansion Funding 3
... study from Rhode Island Hospital has found that a change ... contribute to improved outcomes of the victims and to the ... enforcement officers often serve as medical first responders, there is ... or should do, at the scene of an overdose. The ...
... MedNet Solutions , a global life sciences technology ... to announce that Accelovance , an award-winning, full-service ... Vaccines and General Medicine development, has joined the ... as an iMedNet Partner will facilitate Accelovance,s ...
... of Helsinki and Folkhlsan Research Center has identified a ... breeds, the Norwegian Elkhound and the Karelian Bear Dog. ... and a candidate gene for human chondrodysplasias. The finding ... health. A genetic test can now be used to ...
Cached Biology News:Changing laws, attitudes of police response to drug overdose may lead to better outcomes 2MedNet Solutions Proudly Welcomes Accelovance To The iMedNet Partner Program 2MedNet Solutions Proudly Welcomes Accelovance To The iMedNet Partner Program 3New dwarfism mutation identified in dogs 2
(Date:11/26/2014)... 26, 2014 PMG Research, Inc. ... Research is a network of sites that provide clinical research ... 2 million patient lives through its partnerships with large physician ... 11 hub site locations in the Southeastern United States and ... of the board will be held by: Dr. ...
(Date:11/26/2014)... November 25, 2014 Continuing its award-winning ... earned three prestigious MarCom Awards for outstanding creative achievement ... a Platinum MarCom Award, the organization’s top honor, in ... St. Louis held in April of this year. The ... 14,000 attendees. Additionally, Nerium was awarded a Gold MarCom ...
(Date:11/26/2014)... Boston, MA (PRWEB) November 26, 2014 ... and collaboration company is proud to announce that Darren ... Development and Sales. Darren will drive the ... and positive customer experience. , Darren brings ... He has held key roles in channel operations, from ...
(Date:11/26/2014)... MINNEAPOLIS , Nov. 25, 2014 Bio-Techne ... it has appointed Robert Gavin to serve ... of the Protein Platforms Division.  Mr. Gavin will be ... business segment, which includes the ProteinSimple business acquired in ... San Jose, California -based ProteinSimple ...
Breaking Biology Technology:PMG Research Names Medical Advisory Board 2PMG Research Names Medical Advisory Board 3Nerium International™ Wins One Platinum, Two Gold MarCom Awards 2SoundConnect Appoints Director of Channel Development & Sales 2Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 2Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 3
... Neuralstem, Inc. (NYSE Alternext US: CUR) announced ... present at the 11th Annual BIO CEO & ... 2009, at the Waldorf=Astoria Hotel, New York City.(Logo: ... February 9, 2009 at 10:00 a.m. Eastern Time.The ...
... Advances, Inc. (Cancer Advances), a Cato BioVentures portfolio company, ... all the technology and intellectual property for a suite ... in three gastrointestinal cancers. Cancer Advances was created as ... products developed to inhibit the hormone, gastrin, for an ...
... First proton pump inhibitor (PPI) with a ... OSAKA, Japan, Jan. 30 Takeda Pharmaceutical ... Pharmaceuticals North America, Inc., today announced that ... approved KAPIDEX(TM) (dexlansoprazole) delayed release capsules for ...
Cached Biology Technology:Neuralstem to Present at the 11th Annual BIO CEO & Investor Conference 2Cancer Advances Acquires the Intellectual Property for a Suite of Products that Enhance the Immune System in Treatment of Gastric, Pancreatic, and Colorectal Cancers 2Cancer Advances Acquires the Intellectual Property for a Suite of Products that Enhance the Immune System in Treatment of Gastric, Pancreatic, and Colorectal Cancers 3FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD 2FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD 3FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD 4